The Discounted Cash Flow (DCF) valuation of Mersana Therapeutics Inc (MRSN) is (57.96) USD. With the latest stock price at 2.15 USD, the upside of Mersana Therapeutics Inc based on DCF is -2795.6%.
Note: valuation result may not be accurate due to the company's negative earnings.
| Range | Selected | |
| WACC / Discount Rate | 6.2% - 9.4% | 7.8% |
| Long-term Growth Rate | 3.0% - 5.0% | 4.0% |
| Fair Price | (176.57) - (35.47) | (57.96) |
| Upside | -8312.7% - -1749.6% | -2795.6% |